investorscraft@gmail.com

Stock Analysis & ValuationEvolus, Inc. (EOLS)

Previous Close
$5.33
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)36.72589
Intrinsic value (DCF)26.70401
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

520 Newport Center Drive
Newport Beach, CA 92660
United States
Phone: 949 284 4555
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
CEO: David Moatazedi
Full Time Employees: 372

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

HomeMenuAccount